{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":9909952512,"fmt":"9.91B","longFmt":"9,909,952,512"},"forwardPE":{"raw":50.64103,"fmt":"50.64"},"profitMargins":{"raw":0.062750004,"fmt":"6.28%"},"floatShares":{"raw":19585188,"fmt":"19.59M","longFmt":"19,585,188"},"sharesOutstanding":{"raw":77350000,"fmt":"77.35M","longFmt":"77,350,000"},"sharesShort":{},"sharesShortPriorMonth":{},"sharesShortPreviousMonthDate":{},"dateShortInterest":{},"sharesPercentSharesOut":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":-0.682736,"fmt":"-0.68"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":6.902,"fmt":"6.90"},"priceToBook":{"raw":17.168936,"fmt":"17.17"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{"raw":1514678400,"fmt":"2017-12-31"},"earningsQuarterlyGrowth":{"raw":0.882,"fmt":"88.20%"},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":181148000,"fmt":"181.15M","longFmt":"181,148,000"},"trailingEps":{"raw":2.335,"fmt":"2.34"},"forwardEps":{"raw":2.34,"fmt":"2.34"},"pegRatio":{},"lastSplitFactor":null,"lastSplitDate":{},"enterpriseToRevenue":{"raw":3.433,"fmt":"3.43"},"enterpriseToEbitda":{"raw":27.179,"fmt":"27.18"},"52WeekChange":{"raw":"Infinity","fmt":"âˆž%"},"SandP52WeekChange":{"raw":0.17201865,"fmt":"17.20%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"earnings":{"maxAge":86400,"earningsChart":{"quarterly":[{"date":"4Q2016","actual":{"raw":0.4,"fmt":"0.40"},"estimate":{"raw":0.39,"fmt":"0.39"}}],"currentQuarterEstimateDate":"1Q","currentQuarterEstimateYear":2017},"financialsChart":{"yearly":[{"date":2014,"revenue":{"raw":1230112000,"fmt":"1.23B","longFmt":"1,230,112,000"},"earnings":{"raw":42643000,"fmt":"42.64M","longFmt":"42,643,000"}},{"date":2015,"revenue":{"raw":1515516000,"fmt":"1.52B","longFmt":"1,515,516,000"},"earnings":{"raw":41575000,"fmt":"41.58M","longFmt":"41,575,000"}},{"date":2016,"revenue":{"raw":2021988000,"fmt":"2.02B","longFmt":"2,021,988,000"},"earnings":{"raw":73243000,"fmt":"73.24M","longFmt":"73,243,000"}},{"date":2017,"revenue":{"raw":2492685000,"fmt":"2.49B","longFmt":"2,492,685,000"},"earnings":{"raw":114135000,"fmt":"114.14M","longFmt":"114,135,000"}}],"quarterly":[{"date":"1Q2017","revenue":{"raw":643541000,"fmt":"643.54M","longFmt":"643,541,000"},"earnings":{"raw":31225000,"fmt":"31.23M","longFmt":"31,225,000"}},{"date":"2Q2017","revenue":{"raw":602688000,"fmt":"602.69M","longFmt":"602,688,000"},"earnings":{"raw":35412000,"fmt":"35.41M","longFmt":"35,412,000"}},{"date":"3Q2017","revenue":{"raw":748495000,"fmt":"748.5M","longFmt":"748,495,000"},"earnings":{"raw":56669000,"fmt":"56.67M","longFmt":"56,669,000"}},{"date":"4Q2017","revenue":{"raw":884212000,"fmt":"884.21M","longFmt":"884,212,000"},"earnings":{"raw":58368000,"fmt":"58.37M","longFmt":"58,368,000"}}]},"financialCurrency":"INR"},"summaryProfile":{"address1":"Dorr Oliver House","address2":"2nd Floor B D Sawant Marg Chakala, Andheri East","city":"Mumbai","zip":"400099","country":"India","phone":"91 22 6726 1000","fax":"91 22 6726 1067","website":"http://www.guficbio.com","industry":"Drugs - Generic","sector":"Healthcare","longBusinessSummary":"Gufic Biosciences Limited manufactures and sells pharmaceuticals, herbal products, and active pharmaceutical ingredients in India. It manufactures lyophilized injections. Its lyophilized products include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor; pharmaceutical products comprise Spark, Criti Care, and Ferticare, as well as Criticare life products for the infectious diseases and life threatening infections; bulk drugs, such as antifungals, anaesthetics, and immuno suppressant, as well as intermediates for antifungals; and personal care products. The company also provides contract manufacturing services. Gufic Biosciences Limited supplies its products to hospital chains and medical facilities. It also exports its products. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.","fullTimeEmployees":1023,"companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":118.5,"fmt":"118.50"},"targetHighPrice":{},"targetLowPrice":{},"targetMeanPrice":{},"targetMedianPrice":{},"recommendationMean":{"raw":2.0,"fmt":"2.00"},"recommendationKey":"buy","numberOfAnalystOpinions":{},"totalCash":{"raw":231852992,"fmt":"231.85M","longFmt":"231,852,992"},"totalCashPerShare":{"raw":2.979,"fmt":"2.98"},"ebitda":{"raw":364615008,"fmt":"364.62M","longFmt":"364,615,008"},"totalDebt":{"raw":744556992,"fmt":"744.56M","longFmt":"744,556,992"},"quickRatio":{},"currentRatio":{},"totalRevenue":{"raw":2886895104,"fmt":"2.89B","longFmt":"2,886,895,104"},"debtToEquity":{"raw":138.972,"fmt":"138.97"},"revenuePerShare":{"raw":37.216,"fmt":"37.22"},"returnOnAssets":{},"returnOnEquity":{},"grossProfits":{"raw":1272187000,"fmt":"1.27B","longFmt":"1,272,187,000"},"freeCashflow":{},"operatingCashflow":{},"earningsGrowth":{"raw":0.875,"fmt":"87.50%"},"revenueGrowth":{"raw":0.359,"fmt":"35.90%"},"grossMargins":{"raw":0.50786996,"fmt":"50.79%"},"ebitdaMargins":{"raw":0.1263,"fmt":"12.63%"},"operatingMargins":{"raw":0.113809995,"fmt":"11.38%"},"profitMargins":{"raw":0.062750004,"fmt":"6.28%"},"financialCurrency":"INR"}}],"error":null}}